These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32582679)

  • 1. An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways.
    Lin E; Lin CH; Hung CC; Lane HY
    Front Bioeng Biotechnol; 2020; 8():569. PubMed ID: 32582679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of
    Lin E; Lin CH; Lai YL; Huang CH; Huang YJ; Lane HY
    Front Psychiatry; 2018; 9():566. PubMed ID: 30459659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Logistic ridge regression to predict bipolar disorder using mRNA expression levels in the N-methyl-D-aspartate receptor genes.
    Lin E; Lin CH; Lane HY
    J Affect Disord; 2022 Jan; 297():309-313. PubMed ID: 34718036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Antidepressant Treatment Response and Remission Using an Ensemble Machine Learning Framework.
    Lin E; Kuo PH; Liu YL; Yu YW; Yang AC; Tsai SJ
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33065962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection.
    Lin E; Lin CH; Lane HY
    Sci Rep; 2021 May; 11(1):10179. PubMed ID: 33986383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View.
    Jagannath V; Brotzakis ZF; Parrinello M; Walitza S; Grünblatt E
    Front Mol Neurosci; 2017; 10():342. PubMed ID: 29114206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bagging ensemble machine learning framework to predict overall cognitive function of schizophrenia patients with cognitive domains and tests.
    Lin E; Lin CH; Lane HY
    Asian J Psychiatr; 2022 Mar; 69():103008. PubMed ID: 35051726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions.
    Lin E; Lin CH; Lane HY
    Sci Rep; 2021 Mar; 11(1):6922. PubMed ID: 33767310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
    Jagannath V; Gerstenberg M; Correll CU; Walitza S; Grünblatt E
    J Neural Transm (Vienna); 2018 Jan; 125(1):89-102. PubMed ID: 28864885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
    Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of D-Amino Acid Oxidase (
    Jagannath V; Marinova Z; Monoranu CM; Walitza S; Grünblatt E
    Front Neuroanat; 2017; 11():31. PubMed ID: 28428746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of
    Jagannath V; Theodoridou A; Gerstenberg M; Franscini M; Heekeren K; Correll CU; Rössler W; Grünblatt E; Walitza S
    Front Psychiatry; 2017; 8():292. PubMed ID: 29326614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
    Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
    Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.
    Howley E; Bestwick M; Fradley R; Harrison H; Leveridge M; Okada K; Fieldhouse C; Farnaby W; Canning H; Sykes AP; Merchant K; Hazel K; Kerr C; Kinsella N; Walsh L; Livermore DG; Hoffman I; Ellery J; Mitchell P; Patel T; Carlton M; Barnes M; Miller DJ
    Neurochem Res; 2017 Nov; 42(11):3279-3288. PubMed ID: 28780732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers.
    Lin E; Kuo PH; Liu YL; Yu YW; Yang AC; Tsai SJ
    Front Psychiatry; 2018; 9():290. PubMed ID: 30034349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene.
    Sehgal SA; Khattak NA; Mir A
    Theor Biol Med Model; 2013 Jan; 10():3. PubMed ID: 23286827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of G72 and D-amino acid oxidase genes with schizophrenia.
    Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
    Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker.
    Akyol ES; Albayrak Y; Aksoy N; Şahin B; Beyazyüz M; Kuloğlu M; Hashimoto K
    Acta Neuropsychiatr; 2017 Apr; 29(2):80-86. PubMed ID: 27412497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis.
    Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Del-Ben CM; Louzada-Junior P
    Schizophr Res; 2018 Dec; 202():55-63. PubMed ID: 29935886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
    Corvin A; Donohoe G; McGhee K; Murphy K; Kenny N; Schwaiger S; Nangle JM; Morris D; Gill M
    Neurosci Lett; 2007 Oct; 426(2):97-100. PubMed ID: 17890006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.